Nelson Cruz

Nelson Cruz likely to accept suspension, leaves Biogenesis-tainted agents

21 Comments

The word Wednesday was that Nelson Cruz might appeal the anticipated 50-game ban handed coming down in the Biogenesis scandal, but Jon Heyman reports that Cruz has decided to serve his time now in anticipation of becoming a free agent this winter.

It was also disclosed that Cruz is leaving the ACES agency, which represented several players expected to get Biogenesis suspensions. Yahoo! Sports’ Jeff Passan says he’s signing on with Adam Katz.

By serving the suspension now, Cruz, who is hitting .269/.330/.511 with 27 homers and 76 RBI, will certainly be a more attractive free agent this winter. Of course, teams will still be wondering how much of his bounce-back season this year was due to PED usage, even though his acquisition of Biogenesis drugs took place last year, when his rate numbers were the worst they’ve been since 2007. Or perhaps he’s simply been cheating all along.

Cruz is also bailing on the Rangers when they dearly need his bat in the middle of the order. Speculation last week was that they felt a less urgent need to trade for an outfielder because they thought he was going to appeal the suspension. The Rangers may welcome Cruz back for the postseason anyway, should they get there, but they probably will opt to go in a different direction this winter.

As for the agent switch, well, it’s no wonder than Cruz wanted to get away from ACES, which formerly represented Melky Cabrera when he was suspended and also handles Biogenesis-connected players Jhonny Peralta, Gio Gonzalez, Jesus Montero. Fautino De Los Santos and Cesar Puello, according to MLBTR’s agency database. The Brooklyn-based agency, run by brothers Seth and Sam Levinson, is or at least was being investigated by MLB for links to Biogenesis.

Update: The new names revealed in the Biogenesis scandal today — Antonio Bastardo, Sergio Escalona and Jordany Valdespin — are all ACES clients as well.

Red Sox could go to arbitration hearing with Fernando Abad

BOSTON, MA - SEPTEMBER 16:  Fernando Abad #58 of the Boston Red Sox pitches against the New York Yankees during the ninth inning at Fenway Park on September 16, 2016 in Boston, Massachusetts.  (Photo by Maddie Meyer/Getty Images)
Getty Images
Leave a comment

The Red Sox are expecting to go to an arbitration hearing with left-handed reliever Fernando Abad, per Pete Abraham of the Boston Globe. Red Sox president Dave Dombrowski said there was a “decent chance” a hearing would be necessary after countering Abad’s $2.7 million request with $2 million.

Abad, 31, pitched just 12 2/3 innings for Boston after the club acquired him from Minnesota at the trade deadline last season. The lefty earned a cumulative 3.66 ERA, 4.2 BB/9 and 7.9 SO/9 for the two teams in 2016. He received $1.25 million in 2016 and will remain under club control (through arbitration) in 2017. A $2.7 million salary would be a hefty increase for the veteran reliever, who has seen a significant decline since he put up a 1.57 ERA for the Athletics in 2014 and who has not amassed more than 0.6 fWAR in any single season to date.

While the Red Sox aren’t close to settling with Abad, Evan Drellich of the Boston Herald reports that they may be closing in on a settlement with left-handed starter Drew Pomeranz. Pomeranz filed at $5.7 million, while the Sox felt more comfortable at $3.6 million. The two are expected to meet somewhere in the middle to avoid an arbitration hearing later this winter.

Report: Braves sign Kurt Suzuki

KANSAS CITY, MO - AUGUST 20: Kurt Suzuki #8 of the Minnesota Twins hits against the Kansas City Royals at Kauffman Stadium on August 20, 2016 in Kansas City, Missouri. (Photo by Ed Zurga/Getty Images)
Getty Images
1 Comment

The Braves reportedly have a deal in place with free agent catcher Kurt Suzuki, per Chris Cotillo of SB Nation. FOX Sports’ Ken Rosenthal adds that the contract is for one year, $1.5 million with up to $2.5 million in additional incentives.

Suzuki, 33, completed a three-year track with the Twins in 2016, slashing .258/.301/.403 with eight home runs in 373 PA. The veteran backstop likely won’t provide an offensive or defensive upgrade over current starter Tyler Flowers, but should give the Braves some depth at a position they’ve been looking to strengthen since the start of the offseason.

The team has yet to confirm the deal.